Assessment of the circulating soluble endothelial cell adhesion molecules and pentraxin 3 levels in predicting preterm delivery within 72 h

[LANGUAGE= "English"] INTRODUCTION: The study aimed to evaluate maternal serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), and PTX-3 concentrations in patients with threatened preterm labor (TPL...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International Journal of Medical Biochemistry 2023-01, Vol.6 (1), p.1
Hauptverfasser: Davutoglu, Ebru Alici, Firat, Asuman Akkaya, Ozel, Aysegul, Madazli, Riza
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[LANGUAGE= "English"] INTRODUCTION: The study aimed to evaluate maternal serum soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), and PTX-3 concentrations in patients with threatened preterm labor (TPL) and to predict preterm delivery within 72 h after hospitalization. Premature birth is defined as the risk of the newborn being in labor before the 37th week of pregnancy is completed. Preterm birth affects 9–13% of whole pregnancies. The major causes of neonatal morbidity and mortality.METHODS: This study consisted of 54 women with TPL and 31 healthy pregnant women. The TPL group was further divided into two subgroups; patients who gave birth within 72 h after the hospitalization was applied to as a preterm delivery group and who gave birth at ≥37 weeks were referred to as the term delivery group. Maternal serum levels of sICAM-1, sVCAM-1, sE-selectin, and PTX-3 were measured with the use of ELISA kits.RESULTS: Maternal serum sICAM-1 and PTX-3 levels were significantly higher in a preterm delivery group compared with the other two groups (preterm vs. control and preterm vs. term p
ISSN:2587-2362
2618-642X
DOI:10.14744/ijmb.2022.55477